SANGAMO THERAPEUTICS, INC. — Operating Income by Fiscal Year

17 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/f92ed8db-e183-49b4-9af2-13e16021d544/serie/operating-income

Fiscal year	Operating Income	Period	Evidence
FY 2025	$-121.2M	2025-01-01 – 2025-12-31	evidence 0001628280-26-022029
FY 2024	$-104.0M	2024-01-01 – 2024-12-31	evidence 0001628280-25-013088
FY 2023	$-274.0M	2023-01-01 – 2023-12-31	evidence 0001628280-24-010788
FY 2022	$-201.3M	2022-01-01 – 2022-12-31	evidence 0001628280-23-004666
FY 2021	$-183.3M	2021-01-01 – 2021-12-31	evidence 0001628280-22-003819
FY 2020	$-129.6M	2020-01-01 – 2020-12-31	evidence 0001628280-21-003069
FY 2019	$-105.2M	2019-01-01 – 2019-12-31	evidence 0001628280-20-002582
FY 2018	$-77.2M	2018-01-01 – 2018-12-31	evidence 0001564590-19-005808
FY 2017	$-56.4M	2017-01-01 – 2017-12-31	evidence 0001564590-18-004163
FY 2016	$-72.6M	2016-01-01 – 2016-12-31	evidence 0001564590-17-002900
FY 2015	$-46.9M	2015-01-01 – 2015-12-31	evidence 0001564590-16-012882
FY 2014	$-26.8M	2014-01-01 – 2014-12-31	evidence 0001564590-15-000950
FY 2013	$-26.7M	2013-01-01 – 2013-12-31	evidence 0001193125-14-065170
FY 2012	$-22.2M	2012-01-01 – 2012-12-31	evidence 0001193125-13-076887
FY 2011	$-35.8M	2011-01-01 – 2011-12-31	evidence 0001193125-12-073470
FY 2010	$-24.9M	2010-01-01 – 2010-12-31	evidence 0001193125-12-073470
FY 2009	$-19.4M	2009-01-01 – 2009-12-31	evidence 0001193125-12-073470

Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

SANGAMO THERAPEUTICS, INC. — all facts · Revenue · Net Income